Loading clinical trials...
Loading clinical trials...
This study will enroll about 66 participants who experienced a relapse of RRMS that steroids did not help. The doctor will put participants into a treatment group. Each person has an equal chance of b...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mallinckrodt ARD LLC
NCT05359653 · Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, and more
NCT06390930 · Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, and more
NCT03401879 · Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
NCT06715436 · Multiple Sclerosis, Relapsing-Remitting
NCT06389968 · Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
Stanford University Medical Center
Palo Alto, California
Advanced Neurosciences Research LLC
Fort Collins, Colorado
University of South Florida
Bradenton, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions